Summary
- A study of over 30,000 individuals with rectal cancer showed that patients who received chemotherapy were younger, diagnosed in later years, had larger tumors, and were more likely to be married and receive radiotherapy.
- The occurrence of second primary endometrial cancer (SEC) was significantly higher in patients who underwent chemotherapy compared to those who did not.
- Analysis of subgroups showed that various factors like age, race, tumor size, histology, and stage increased the risk of developing SEC after chemotherapy.
- The risk of developing SEC was highest in patients aged 70 and above, diagnosed with rectal cancer between 1985-1994, and had a latency period of 3-119 months.
- Patients with SEC who underwent chemotherapy did not show significant differences in overall survival and cancer-specific survival compared to those who did not receive chemotherapy, but patients with primary endometrial cancer had better outcomes.
A recent study looked at patients with rectal cancer who underwent chemotherapy and found a higher risk of developing second primary endometrial cancer (SEC) compared to those who did not receive chemotherapy. This study spanned 30 years and involved over 30,000 patients diagnosed with rectal cancer. The results showed that patients who received chemotherapy were more likely to develop SEC, especially those who were younger, had larger tumors, and were diagnosed with higher grade cancer.
The study also looked at the survival outcomes of patients with SEC who received chemotherapy versus those who did not. Interestingly, there was no significant difference in overall survival and cancer-specific survival rates between the two groups after 10 years. However, when compared to patients with primary endometrial cancer (PEC), those with SEC had lower survival rates in both chemotherapy and no-chemotherapy groups.
Overall, the study highlights the importance of monitoring patients with rectal cancer who undergo chemotherapy for the potential development of SEC. Keeping a close eye on these patients can help improve outcomes and provide better care.
Source link
Oncology, Ob/Gyn & Women’s Health